Anthropic launches preclinical drug development programs to gain domain experience for building better AI models

You tell me that Anthropic is not blocking the use for drug discovery because of safety concerns, but because they want to prevent competition?!?!?! Who can believe that? What is the next step, Claude Code doesn’t really think my ideas are great? 😱

As stated it’s technically compatible with more of a Logan’s Run type scenario

@scaling01 @scaling01, if you put the smartest people together in one place you get a literary or artistic or scientific _salon_. If you put the most corrupt and greedy people into a room they make hedge funds. Chasing money isn't for smart people, sport.

@scaling01 Every ecosystem develops specialists... builders build while allocators allocate.

Capital allocation is just the highest-leverage interface intelligence has for reshaping reality at scale.

@scaling01 Are you even capable of understanding, @scaling01, that you and @teortaxesTex and @yacineMTB are obsessed with artificial intelligence (and unable to tell the difference between AI and a gibberish machine) precisely because you are dead last in intelligence? You crave the help.

@scaling01 Finaly

@scaling01 anthropic doing neglected diseases is literally a long tail bet with a hedge against the core training business going sideways. the structure of the decision is identical to a citadel pod, just with biology instead of equities

@ziv_ravid Then they might give the drug to small groups for saftey reasons 😆

@ziv_ravid Claude has been restricting drug discovery queries for months. Now Anthropic launches its own preclinical programs.

@scaling01 @teortaxesTex @yacineMTB Smart people aren't solely and wholly obsessed with thinking machines, @scaling01. Greedy stupid people are, because they think they can profit from taking credit for machine intelligence (if any.)